COVID-19 serosurveys for public health decision making

Manoj V Murhekar¹, Hannah Clapham²

Affiliations

¹ Indian Councial of Medical Research, National Institute of Epidemiology, Chennai 600 070, India. Electronic address: mmurhekar@nieicmr.org.in.
² Saw Swee Hock School of Public Health, National University of Singapore, Singapore.

PMID: 33705691
PMCID: PMC8049585
DOI: 10.1016/S2214-109X(21)00057-7

Comment

COVID-19 serosurveys for public health decision making

Manoj V Murhekar et al. Lancet Glob Health. 2021 May.

. 2021 May;9(5):e559-e560.

doi: 10.1016/S2214-109X(21)00057-7. Epub 2021 Mar 8.

Authors

Manoj V Murhekar¹, Hannah Clapham²

Affiliations

¹ Indian Councial of Medical Research, National Institute of Epidemiology, Chennai 600 070, India. Electronic address: mmurhekar@nieicmr.org.in.
² Saw Swee Hock School of Public Health, National University of Singapore, Singapore.

PMID: 33705691
PMCID: PMC8049585
DOI: 10.1016/S2214-109X(21)00057-7

No abstract available

PubMed Disclaimer

Comment on

Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis.
Chen X, Chen Z, Azman AS, Deng X, Sun R, Zhao Z, Zheng N, Chen X, Lu W, Zhuang T, Yang J, Viboud C, Ajelli M, Leung DT, Yu H. Chen X, et al. Lancet Glob Health. 2021 May;9(5):e598-e609. doi: 10.1016/S2214-109X(21)00026-7. Epub 2021 Mar 8. Lancet Glob Health. 2021. PMID: 33705690 Free PMC article.

Cited by

Evolution of SARS-CoV-2 Variants: Implications on Immune Escape, Vaccination, Therapeutic and Diagnostic Strategies.
Zabidi NZ, Liew HL, Farouk IA, Puniyamurti A, Yip AJW, Wijesinghe VN, Low ZY, Tang JW, Chow VTK, Lal SK. Zabidi NZ, et al. Viruses. 2023 Apr 10;15(4):944. doi: 10.3390/v15040944. Viruses. 2023. PMID: 37112923 Free PMC article. Review.
SARS-CoV-2 Seroprevalence in a Rural and Urban Household Cohort during First and Second Waves of Infections, South Africa, July 2020-March 2021.
Kleynhans J, Tempia S, Wolter N, von Gottberg A, Bhiman JN, Buys A, Moyes J, McMorrow ML, Kahn K, Gómez-Olivé FX, Tollman S, Martinson NA, Wafawanaka F, Lebina L, du Toit J, Jassat W, Neti M, Brauer M, Cohen C; PHIRST-C Group. Kleynhans J, et al. Emerg Infect Dis. 2021 Dec;27(12):3020-3029. doi: 10.3201/eid2712.211465. Epub 2021 Sep 3. Emerg Infect Dis. 2021. PMID: 34477548 Free PMC article.
Seroprevalence of anti-SARS-CoV-2 antibodies 6 months into the vaccination campaign in Geneva, Switzerland, 1 June to 7 July 2021.
Stringhini S, Zaballa ME, Pullen N, Perez-Saez J, de Mestral C, Loizeau AJ, Lamour J, Pennacchio F, Wisniak A, Dumont R, Baysson H, Richard V, Lorthe E, Semaani C, Balavoine JF, Pittet D, Vuilleumier N, Chappuis F, Kherad O, Azman AS, Posfay-Barbe K, Kaiser L, Guessous I; Specchio-COVID19 study group. Stringhini S, et al. Euro Surveill. 2021 Oct;26(43):2100830. doi: 10.2807/1560-7917.ES.2021.26.43.2100830. Euro Surveill. 2021. PMID: 34713799 Free PMC article.
Evaluation of SARS-CoV-2 Antibody Response Between Paired Fingerprick (HemaPEN^®) and Venepuncture Collected Samples in Children and Adults.
Mazarakis N, Toh ZQ, Nguyen J, Higgins RA, Rudge J, Whittle B, Woudberg NJ, Devine J, Gooley A, Lapierre F, Crawford NW, Tosif S, Licciardi PV. Mazarakis N, et al. Antibodies (Basel). 2025 Feb 5;14(1):13. doi: 10.3390/antib14010013. Antibodies (Basel). 2025. PMID: 39982228 Free PMC article.
Systematic review of seroprevalence of SARS-CoV-2 antibodies and appraisal of evidence, prior to the widespread introduction of vaccine programmes in the WHO European Region, January-December 2020.
Vaughan A, Duffell E, Freidl GS, Lemos DS, Nardone A, Valenciano M, Subissi L, Bergeri I, K Broberg E, Penttinen P, Pebody R, Keramarou M. Vaughan A, et al. BMJ Open. 2023 Nov 6;13(11):e064240. doi: 10.1136/bmjopen-2022-064240. BMJ Open. 2023. PMID: 37931969 Free PMC article.

See all "Cited by" articles

References

1. Clapham H, Hay J, Routledge I, et al. Sero-epidemiologic study designs for determining SARS-COV-2 transmission and immunity. Emerg Infect Dis. 2020;26:1978–1986. - PMC - PubMed
1. Chen X, Chen Z, Azman A, et al. Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis. Lancet Glob Health. 2021 doi: 10.1016/S2214-109X(21)00026-7. published online March 8. - DOI - PMC - PubMed
1. WHO COVID-19 weekly epidemiological update. 2021. https://www.who.int/docs/default-source/coronaviruse/situation-reports/2...
1. Perez-Saez J, Lauer SA, Kaiser L, et al. Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland. Lancet Infect Dis. 2020 doi: 10.1016/S1473-3099(20)30584-3. published online July 14. - DOI - PMC - PubMed
1. Post N, Eddy D, Huntley C, et al. Antibody response to SARS-CoV-2 infection in humans: a systematic review. PLoS One. 2020;15 - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

COVID-19 serosurveys for public health decision making

Affiliations

COVID-19 serosurveys for public health decision making

Authors

Affiliations

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical